Clinical expertise.
Scientific direction.

Every Nowwell innovation is shaped by a Scientific Advisory of leading urologists and researchers. Their expertise ensures our technologies are grounded in clinical insight and developed to improve care for patients and clinicians worldwide.

Steven A. Kaplan, MD

Mount Sinai Health System

Dean Elterman, MD, MSc, FRCSC

Toronto Western Hospital

Jennifer T. Anger, MD, MPH

University of Arizona College of Medicine–Phoenix

A. Lenore Ackerman, MD, PhD

UCLA Health

Marcus Drake, MD, FRSC

Imperial College London

Advisory Popup Editor

Designer-only CMS section. Edit each advisory member’s popup content here; this section is hidden on the live site.

Marcus Drake, MD, FRSC

Imperial College London

Professor of Neurological Urology at Imperial College London and Honorary Consultant Urologist at Charing Cross Hospital. Professor Drake is a leading international authority on functional urology, neuro-urology, urodynamics and lower urinary tract dysfunction. He has led major clinical research programmes involving urinary catheters and UTI diagnostics and has contributed to NICE and European Association of Urology guideline panels. His experience links catheter innovation directly to clinical evidence, standards of care and real-world implementation.

A. Lenore Ackerman, MD, PhD

UCLA Health

Associate Professor of Urology and Director of Research for Urogynecology and Reconstructive Pelvic Surgery at UCLA. Dr. Ackerman treats men and women with incontinence, voiding dysfunction and pelvic floor disorders, with a particular focus on geriatric urology. Her translational research investigates the biological mechanisms underlying lower urinary tract symptoms, bridging advanced science with day-to-day realities of long-term urinary care.

Jennifer T. Anger, MD, MPH

University of Arizona College of Medicine–Phoenix

Professor and inaugural Chair of the Department of Urology at the University of Arizona College of Medicine, Phoenix. Dr. Anger is a board-certified urologist and internationally recognized specialist in female pelvic medicine, urinary incontinence and reconstructive urology. Her work centers on patient-reported outcomes, quality of care and rigorous clinical evaluation of treatments for complex urinary disorders. She brings valuable leadership in evidence generation and is driving meaningful improvements in care.

Dean Elterman, MD, MSc, FRCSC

Toronto Western Hospital

Urologist at Toronto Western Hospital, Associate Professor at the University of Toronto, and holder of the Lang Family Endowed Chair in Urological Innovation, specializing in functional urology and neuromodulation. Fellowship-trained in voiding dysfunction, neuro-urology, female urology and pelvic reconstruction, Dr. Elterman also holds a master’s degree in clinical epidemiology and health services research. His combined clinical and research experience brings an important perspective on evaluating emerging technologies and translating innovation into routine urological care.

Steven A. Kaplan, MD

Mount Sinai Health System

Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Men’s Wellness Program. Dr. Kaplan is an internationally recognized authority on lower urinary tract symptoms, benign prostatic hyperplasia and voiding dysfunction. His NIH-funded research, landmark clinical studies and more than 600 peer-reviewed publications have helped shape treatment standards worldwide. He brings exceptional insight into clinical evidence generation, guideline development and the adoption of new technologies in urological care.

Steven A. Kaplan, MD

Mount Sinai Health System

Dean Elterman, MD, MSc, FRCSC

Toronto Western Hospital

Jennifer T. Anger, MD, MPH

University of Arizona College of Medicine–Phoenix

A. Lenore Ackerman, MD, PhD

UCLA Health

Marcus Drake, MD, FRSC

Imperial College London